Prior to joining Vistria, Mr. Schulz was at Altaris Capital Partners, a middle-market private equity firm focused on investments in healthcare. At Altaris he was responsible for evaluating and executing transactions across the healthcare industry. Prior to Altaris, Mr. Schulz was with Leerink Partners, a healthcare-focused investment bank. Mr. Schulz began his career with Merrill Lynch in the Global Healthcare Investment Banking Group where he worked on a variety of M&A transactions and equity and debt financings.
Mr. Schulz is actively involved with Vistria’s investments in AIS Healthcare, Alacura, HomeFree Pharmacy, Medulla (dba Chiro One), Mission Healthcare, SCA Pharma, Tango, and Vital Caring Group. He was also involved with Vistria’s prior investments in St. Croix Hospice and AgapeCare.
Mr. Schulz serves as a board member for Rush University Medical Center’s Associate Board and serves on the advisory board for the HI2 – Home Care Innovation + Investment Conference.
Mr. Schulz received a B.S. in Business Administration from the Tepper School of Business at Carnegie Mellon University and an M.B.A. from the Wharton School at the University of Pennsylvania.
